New ointment may soothe radiation mouth pain better than standard rinse
NCT ID NCT07186114
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested two treatments for painful mouth sores caused by radiation therapy: MEBO ointment and Tantum Verde mouthwash. 36 adults with moderate to severe sores were randomly assigned to one treatment for two weeks. Researchers measured soreness and healing at the start, after one week, and after two weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- MEBO ointment and Tantum Verde mouthwash
- What this could lead to
- If MEBO works better, it could offer a new option to ease painful mouth sores from radiation therapy.
- What could go wrong
- This is a small, single-center trial with only 36 patients, so results may not apply broadly. Both treatments are already available, so no major breakthrough is expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
36 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who later on during radiotherapy developed oral mucositis with a severity of WHO score II or more and were over 18 years were then included in the study and allocated to one of the treatment groups . Exclusion Criteria: * We excluded patients who were receiving any prophylactic agents and/or corticosteroids and those who would not sign the informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Oral mucositis (ulcerative) due to radiation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University
Cairo, Egypt
-
Faculty of Dentistry - Cairo University
Cairo, 11553, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drug stop the agony of mouth sores during cancer therapy?
- Taurine: a simple supplement to fight radiation mouth sores?
- Natural mouthwash aimed to soothe radiation mouth sores, but study never started
- Light therapy eases mouth sores and skin burns in 33,000 cancer patients
- Can a stem cell spray stop radiation mouth pain?